Literature DB >> 25063244

Smoking-related idiopathic interstitial pneumonia.

Kevin R Flaherty1, Charlene Fell2, Marie-Christine Aubry3, Kevin Brown4, Thomas Colby5, Ulrich Costabel6, Teri J Franks7, Barry H Gross8, David M Hansell9, Ella Kazerooni8, Dong Soon Kim10, Talmadge E King11, Masanori Kitachi12, David Lynch13, Jeff Myers14, Sonoko Nagai15, Andrew G Nicholson16, Venerino Poletti17, Ganesh Raghu18, Moises Selman19, Galen Toews20, William Travis21, Athol U Wells22, Robert Vassallo23, Fernando J Martinez24.   

Abstract

Cigarette smoking is a key factor in the development of numerous pulmonary diseases. An international group of clinicians, radiologists and pathologists evaluated patients with previously identified idiopathic interstitial pneumonia (IIP) to determine unique features of cigarette smoking. Phase 1 (derivation group) identified smoking-related features in patients with a history of smoking (n=41). Phase 2 (validation group) determined if these features correctly predicted the smoking status of IIP patients (n=100) to participants blinded to smoking history. Finally, the investigators sought to determine if a new smoking-related interstitial lung disease phenotype could be defined. Phase 1 suggested that preserved forced vital capacity with disproportionately reduced diffusing capacity of the lung for carbon monoxide, and various radiographic and histopathological findings were smoking-related features. In phase 2, the kappa coefficient among clinicians was 0.16 (95% CI 0.11-0.21), among the pathologists 0.36 (95% CI 0.32-0.40) and among the radiologists 0.43 (95% CI 0.35-0.52) for smoking-related features. Eight of the 100 cases were felt to represent a potential smoking-related interstitial lung disease. Smoking-related features of interstitial lung disease were identified in a minority of smokers and were not specific for smoking. This study is limited by its retrospective design, the potential for recall bias in smoking history and lack of information on second-hand smoke exposure. Further research is needed to understand the relationship between smoking and interstitial lung disease. ©ERS 2014.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25063244      PMCID: PMC4366053          DOI: 10.1183/09031936.00166813

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  27 in total

1.  The syndrome of combined pulmonary fibrosis and emphysema.

Authors:  Vincent Cottin; Jean-François Cordier
Journal:  Chest       Date:  2009-07       Impact factor: 9.410

2.  Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity.

Authors:  V Cottin; H Nunes; P-Y Brillet; P Delaval; G Devouassoux; I Tillie-Leblond; D Israel-Biet; I Court-Fortune; D Valeyre; J-F Cordier
Journal:  Eur Respir J       Date:  2005-10       Impact factor: 16.671

3.  Correlation of structure and function in idiopathic pulmonary fibrosis.

Authors:  R M Cherniack; T V Colby; A Flint; W M Thurlbeck; J A Waldron; L Ackerson; M I Schwarz; T E King
Journal:  Am J Respir Crit Care Med       Date:  1995-04       Impact factor: 21.405

Review 4.  Combined pulmonary fibrosis and emphysema syndrome: a review.

Authors:  Matthew D Jankowich; Sharon I S Rounds
Journal:  Chest       Date:  2012-01       Impact factor: 9.410

5.  Vertical gradients of lung density in supine subjects with fibrosing alveolitis or pulmonary emphysema.

Authors:  A B Millar; D M Denison
Journal:  Thorax       Date:  1990-08       Impact factor: 9.139

6.  Desquamative interstitial pneumonia and respiratory bronchiolitis-associated interstitial lung disease.

Authors:  Jay H Ryu; Jeffrey L Myers; Stephen A Capizzi; William W Douglas; Robert Vassallo; Paul A Decker
Journal:  Chest       Date:  2005-01       Impact factor: 9.410

7.  Pulmonary emphysema followed by pulmonary fibrosis of undetermined cause.

Authors:  N Hiwatari; S Shimura; T Takishima
Journal:  Respiration       Date:  1993       Impact factor: 3.580

8.  Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension.

Authors:  Mayra Mejía; Guillermo Carrillo; Jorge Rojas-Serrano; Andrea Estrada; Teresa Suárez; Delfino Alonso; Emilio Barrientos; Miguel Gaxiola; Carmen Navarro; Moisés Selman
Journal:  Chest       Date:  2009-02-18       Impact factor: 9.410

9.  Smoking and pulmonary fibrosis: novel insights.

Authors:  Katerina D Samara; George Margaritopoulos; Athol U Wells; Nikolaos M Siafakas; Katerina M Antoniou
Journal:  Pulm Med       Date:  2011-06-15

10.  Combined Pulmonary Fibrosis and Emphysema Syndrome: A New Phenotype within the Spectrum of Smoking-Related Interstitial Lung Disease.

Authors:  Karina Portillo; Josep Morera
Journal:  Pulm Med       Date:  2012-02-09
View more
  5 in total

1.  Interstitial lung abnormalities detected incidentally on CT: a Position Paper from the Fleischner Society.

Authors:  Hiroto Hatabu; Gary M Hunninghake; Luca Richeldi; Kevin K Brown; Athol U Wells; Martine Remy-Jardin; Johny Verschakelen; Andrew G Nicholson; Mary B Beasley; David C Christiani; Raúl San José Estépar; Joon Beom Seo; Takeshi Johkoh; Nicola Sverzellati; Christopher J Ryerson; R Graham Barr; Jin Mo Goo; John H M Austin; Charles A Powell; Kyung Soo Lee; Yoshikazu Inoue; David A Lynch
Journal:  Lancet Respir Med       Date:  2020-07       Impact factor: 30.700

Review 2.  Demystifying idiopathic interstitial pneumonia: time for more etiology-focused nomenclature in interstitial lung disease.

Authors:  Nevins W Todd; Sergei P Atamas; Stella E Hines; Irina G Luzina; Nirav G Shah; Edward J Britt; Andrew J Ghio; Jeffrey R Galvin
Journal:  Expert Rev Respir Med       Date:  2022-01-31       Impact factor: 3.772

Review 3.  The diagnosis of idiopathic pulmonary fibrosis: current and future approaches.

Authors:  Fernando J Martinez; Alison Chisholm; Harold R Collard; Kevin R Flaherty; Jeffrey Myers; Ganesh Raghu; Simon L F Walsh; Eric S White; Luca Richeldi
Journal:  Lancet Respir Med       Date:  2016-12-06       Impact factor: 30.700

4.  A confusing case report of pulmonary langerhans cell histiocytosis and literature review.

Authors:  Yang Li; Wang Zhen; Ulrich Costable; Xu Jun; Ren Zhe; Mao YuPing
Journal:  Open Med (Wars)       Date:  2016-06-15

5.  A comprehensive assessment of environmental exposures and the medical history guides multidisciplinary discussion in interstitial lung disease.

Authors:  Neal Dodia; Diana Amariei; Blaine Kenaa; Doug Corwin; Lydia Chelala; E James Britt; Ashutosh Sachdeva; Irina G Luzina; Jeffrey D Hasday; Nirav G Shah; Sergei P Atamas; Teri J Franks; Allen P Burke; Stella E Hines; Jeffrey R Galvin; Nevins W Todd
Journal:  Respir Med       Date:  2021-02-11       Impact factor: 3.415

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.